Sign in

CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
460574869
Phone
(857) 284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 17,544 shares at $3.49 ($61,144)
  3. 4 Derivatives Options or other derivatives
  4. 4 Option exercise Director acquired 33,150 shares (option exercise)
  5. 4 Option exercise Director acquired 33,150 shares (option exercise)
  6. 4 Option exercise Director acquired 33,150 shares (option exercise)
  7. 4 Option exercise Director acquired 33,150 shares (option exercise)
  8. 4 Option exercise Director acquired 33,150 shares (option exercise)
  9. 4 Option exercise Director acquired 33,150 shares (option exercise)
  10. 4 Planned sale President, CEO, and Chairman sold 1,006 shares at $4.00 ($4,024)
  11. 4 Open-market sale See Remarks sold 15,843 shares at $3.84 ($60,915)
  12. 4 Planned sale President, CEO, and Chairman sold 56,910 shares at $3.85 ($218,819)
  13. 4 Open-market sale Chief Medical Officer sold 15,870 shares at $3.84 ($60,963)
  14. 4 Open-market sale EVP, Chief Accounting Officer sold 12,477 shares at $3.84 ($47,904)
  15. 4 Open-market sale Chief Commercial Officer sold 11,819 shares at $3.84 ($45,420)
  16. 4 Open-market sale Chief Development Officer sold 14,029 shares at $3.84 ($53,913)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 127 filings